Two Biologics Show No Difference in Axial Spondyloarthritis

This study represents the first head-to-head trial comparing the effects of two biologics in axial spondyloarthritis, in this case in patients at high risk for radiographic progression.
Medscape Medical News

source https://www.medscape.com/viewarticle/992645?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost